---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-167299"
form_type: "8-K"
ticker: "TCRX"
cik: "0001783328"
company_name: "TScan Therapeutics, Inc."
filed_at: "2022-06-03T23:59:59+00:00"
generated_at: "2026-06-25T04:50:26.091501+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# TScan promotes Gavin MacBeath to CSO and COO; salary raised to $470k

## Summary
- Gavin MacBeath, Ph.D., promoted from CSO to Chief Scientific and Operations Officer effective June 1, 2022.
- Annual base salary increased to $470,000 in connection with promotion.
- Stockholders elected Timothy Barberich and Stephen Biggar as Class I directors for three-year terms.
- Ratification of Deloitte & Touche as independent auditor for FY2022 approved with 11.5M votes for, 425 against.
- All votes at Annual Meeting held June 1, 2022; results filed via 8-K.

## SEC filing metadata
- accession: 0001193125-22-167299
- form_type: 8-K
- ticker: TCRX
- cik: 0001783328
- company_name: TScan Therapeutics, Inc.
- filed_at: 2022-06-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1783328/000119312522167299/0001193125-22-167299-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1783328/000119312522167299/d348966d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-167299
- JSON: https://secwatch.observer/filing/0001193125-22-167299.json
- Plain text: https://secwatch.observer/filing/0001193125-22-167299.txt

## Key facts
- Executive change
  Gavin MacBeath changed role as Chief Scientific and Operations Officer at TScan Therapeutics, Inc..
  - Action: promoted
  - Role: Chief Scientific and Operations Officer
  source text: On June 1, 2022, the Board of Directors (the “Board”) of TScan Therapeutics, Inc. (the “Company”) promoted Gavin MacBeath, Ph.D. to Chief Scientific and Operations Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1783328/000119312522167299/0001193125-22-167299-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.